| GENE_SYMBOL |
HGNC_ID |
UNIPROT_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| TYRO3 |
HGNC:12446 |
Q06418 |
(S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide |
11152667 |
DSigDB |
| TYRO3 |
HGNC:12446 |
Q06418 |
Ast-487 |
11409972 |
DGidb |
| TYRO3 |
HGNC:12446 |
Q06418 |
Crizotinib |
11626560 |
DSigDB, Pubchem |
| TYRO3 |
HGNC:12446 |
Q06418 |
FOSTAMATINIB |
11671467 |
DrugBank |
| TYRO3 |
HGNC:12446 |
Q06418 |
4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid |
11712649 |
ChemBL, DGidb, Pubchem |
| TYRO3 |
HGNC:12446 |
Q06418 |
5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine |
16038120 |
ChemBL |
| TYRO3 |
HGNC:12446 |
Q06418 |
N-Propyl-4-({4-[(2,2,2-trifluoroethyl)amino]-1H-pyrrolo[2,3-d]pyrimidin-2-yl}amino)benzamide |
16129448 |
ChemBL, TTD |
| TYRO3 |
HGNC:12446 |
Q06418 |
Bms-777607 |
24794418 |
ChemBL, GtoPDB, Pubchem, TTD |
| TYRO3 |
HGNC:12446 |
Q06418 |
Adavosertib |
24856436 |
DGidb |
| TYRO3 |
HGNC:12446 |
Q06418 |
Sns-314 |
24995524 |
DGidb |
| TYRO3 |
HGNC:12446 |
Q06418 |
Cabozantinib |
25102847 |
DSigDB |
| TYRO3 |
HGNC:12446 |
Q06418 |
Lck inhibitor 2 |
25138012 |
ChemBL |
| TYRO3 |
HGNC:12446 |
Q06418 |
Foretinib |
42642645 |
Pubchem |
| TYRO3 |
HGNC:12446 |
Q06418 |
3-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenol |
44381237 |
ChemBL |
| TYRO3 |
HGNC:12446 |
Q06418 |
Nps-1034 |
46194178 |
ChemBL |
| TYRO3 |
HGNC:12446 |
Q06418 |
Ilorasertib |
46207586 |
DGidb |
| TYRO3 |
HGNC:12446 |
Q06418 |
Bemcentinib |
46215462 |
ChemBL, Pubchem, TTD |
| TYRO3 |
HGNC:12446 |
Q06418 |
2-{[(3r,4r)-3-Aminotetrahydro-2h-Pyran-4-Yl]amino}-4-[(4-Methylphenyl)amino]pyrimidine-5-Carboxamide |
46865656 |
ChemBL |
| TYRO3 |
HGNC:12446 |
Q06418 |
3-[4-Amino-7-[3-(hydroxymethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-5-yl]phenol |
49825075 |
ChemBL |
| TYRO3 |
HGNC:12446 |
Q06418 |
Unc569 |
53355503 |
ChemBL, TTD |